Is a complete TLV/ORMP research report available?

No complete published report is available for tlv/ORMP (TLV/ORMP) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

TLV/ORMP (TLV/ORMP)

Tel Aviv Stock Exchange: TLV/ORMP · ILA

ILA 1,350

+108.96 (+8.8%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-08-02 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first TLV/ORMP analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	510.7M
Net income (ttm)	344.8M
EPS (ttm)	ILA 8.12
P/E (trailing)	1.5x
Dividend	ILA 0.79 (6.33%)
Volume	152
Beta	1.20

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): 344.8M
EPS (ttm): ILA 8.12
P/E (trailing): 1.5x
Market cap: 510.7M

All TLV/ORMP indicators

Market & fundamental data

Available fields

167

Groups with data

Currency

USD

Showing 167 of 167 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	IL
Employees	4
Enterprise value	ILA 256.1M
Exchange	Tel Aviv Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Biotechnology
Isin	US68403P2039
Last refreshed	2026-08-02
Market cap	ILA 510.7M
Price	ILA 1,350
Price currency	ILA
Sector	Healthcare
Sector PE	61.79
Sector PE Fwd	12.46
Sic	2836
Symbol	tlv/ORMP
Website	https://oramed.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	67.51%
EV Earnings	0.74x
FCF yield	-5.29%
P/B ratio	0.68x
P/E ratio	1.48x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	ILA 344.8M
Net Income Growth Quarters	4%
Net Income Growth Years	2%
Profit Per Employee	ILA 86.2M
Profitable Quarters	ILA 4
Profitable Years	1
ROA	-4.28
ROCE	-5.52
ROE	58.16
ROIC	-9.59
Roic5y	-157

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	96.93%
Cagr3y	6.89%
Cagr5y	-20%
EPS Growth Quarters	4
EPS Growth Years	2
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	ILA 848.8M
Cash	ILA 207.9M
Current Assets	ILA 208.7M
Current Liabilities	ILA 32.4M
Debt	ILA 2.4M
Debt Equity	ILA 0
Debt FCF	ILA -0.09
Equity	ILA 752.3M
Liabilities	ILA 96.5M
Long Term Assets	ILA 640.1M
Long Term Liabilities	ILA 64.2M
Net Cash	ILA 262.2M
Net Cash By Market Cap	ILA 51.34
Net Cash Growth	-36.29%
Net Debt Equity	ILA -0.35
Tangible Book Value	ILA 752.3M
Tangible Book Value Per Share	ILA 18.38
WACC	10.8

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	6.45
Net Working Capital	ILA -25.2M
Quick ratio	6.28
Working Capital	ILA 181.8M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-4.04%
Dividend Growth	0%
Dividend Growth Years	0%
Dividend per share	ILA 0.79
Dividend Years	1
Dividend Yield	6.33%
Ex Div Date	2026-01-16
Last Dividend	ILA 0.79
Payout Ratio	9.42%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	96.84%
200-day SMA	1,051.3
3Y total return	22.13%
50-day SMA	1,217.9
50-day SMA vs 200-day SMA	50over200
5Y total return	-67.22%
All Time High	9,856
All Time High Change	-86.3%
All Time High Date	2021-11-03
All Time Low	653.7
All Time Low Change	106.52%
All Time Low Date	2023-01-29
ATR	75.1
Beta	1.2
Ch YTD	49.72
High	1,350
High52	1,500
High52 Date	2026-06-26
High52ch	-10%
Low	1,241
Low52	680
Low52 Date	2025-08-13
Low52ch	98.53%
Ma50ch	10.84%
Price vs 200-day SMA	28.41%
RSI	58.74
RSI Monthly	59.54
RSI Weekly	58.31
Sharpe ratio	1.5x
Sortino ratio	2.6
Total Return	2.29%
Tr YTD	60.91
Tr1m	-3.71%
Tr1w	4.25%
Tr3m	17.7%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	ILA -45M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	31,593,219%
Shares Insiders	17.64%
Shares Institutions	22.53%
Shares Qo Q	2.61%
Shares Yo Y	4.04%
Short Ratio	2.61

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	ILA -44.5M
Adjusted OCF	-44,454,784
Average Volume	4,757.45x
Bv Per Share	18.38
CAPEX	ILA -34,730
Ch1m	-3.71
Ch1w	4.25
Ch1y	83.15
Ch3m	17.7
Ch3y	13.64
Ch5y	-69.5
Ch6m	29.06
Change	8.78%
Change From Open	8.78
Close	1,241
Days Gap	0
Depreciation Amortization	370,618.2
Dollar Volume	205,200
Earnings Date	2026-08-12
EBIT	ILA -45M
EBITDA	ILA -44.6M
EPS	ILA 8.12
F Score	1
FCF	ILA -27M
FCF EV Yield	-10.54x
Financing CF	-47,691,017
Fiscal Year End	December
Founded	2,002
Graham Number	6385.77622
Graham Upside	373
Income Tax	ILA 69M
Investing CF	-118,907,075
Is Primary Listing	0
Last Earnings Date	2025-11-07
Last Report Date	2026-03-31
Ma150	1,127.1
Ma150ch	19.77%
Ma20	1,276.9
Ma20ch	5.72%
Net CF	-193,586,692
Next Earnings Date	2026-08-12
Open	1,241
Payment Date	2026-01-26
Position In Range	100
Ppne	3,813,385.2
Price Date	2026-07-31
Ptbv Ratio	0.68
Relative Volume	0.03x
Share Based Comp	17,488,285
Tax Rate	16.58%
Tr6m	29.06%
Volume	152
Z Score	1.69

TLV/ORMP (TLV/ORMP)

Coverage state: Market snapshot only — no published research

Generate the first TLV/ORMP analysis

Price

Financial snapshot

Fair-value bridge

Latest news · TLV/ORMP

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TLV/ORMP indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on TLV/ORMP

Frequently asked questions